This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Shire Plc CEO Discusses Q4 2010 Results - Earnings Call Transcript

Shire plc ( SHPGY)

Q4 2010 Earnings Call

February 10, 2011 9:00 am ET


Eric Rojas - Director, North America Investor Relations

Angus Russell - Chief Executive Officer

Graham Hetherington - Chief Financial Office

Mike Cola - President, Specialty Pharmaceuticals

Sylvie Grégoire - President, Human Genetic Therapies


Ken Cacciatore - Cowen and Company, LLC.

Peter Verdult - Morgan Stanley Dean Witter

David Buck - Buckingham Research Group

Kerry Holford - Credit Suisse

David Steinberg - Deutsche Bank Securities Inc.

Graham Parry - Merrill Lynch

Brian Bourdot - Barclays Capital

Frank Pinkerton - SunTrust Robinson Humphrey



A very good day to you, ladies and gentlemen. Welcome to the Shire 2010 Full-Year Results Conference Call hosted by Angus Russell. My name is Nancy, I'm the operator for the call today. Your lines will remain on listen-only throughout the conference. (Operator Instructions) I'd like to advice all parties this call is being recorded for replay purposes.

I would now like to hand the call over to Eric Rojas. Please go ahead.

Eric Rojas

Thanks, Nancy. Good morning and good afternoon, everyone. Thank you for joining us today for Shire's full-year 2010 financial results. By now you should have all received our press release and should be viewing our presentation via our website on If for some reasons you have not received the press release or are unable to access our website, please contact Souheil Salah in our UK Investor Relations Department on +44-1256-894-160 and he will be happy to assist you.

1 of 5

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 16,472.37 +200.36 1.23%
S&P 500 1,951.36 +27.54 1.43%
NASDAQ 4,707.7750 +80.6910 1.74%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs